
ShockWave Medical SWAV
Quarterly report 2024-Q1
added 05-06-2024
ShockWave Medical Total Assets 2011-2026 | SWAV
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets ShockWave Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.57 B | 646 M | 346 M | 272 M | 232 M | 53.4 M | 59.3 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.57 B | 53.4 M | 454 M |
Quarterly Total Assets ShockWave Medical
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.64 B | 1.47 B | 787 M | 783 M | 646 M | 476 M | 417 M | 373 M | 346 M | 299 M | 276 M | 269 M | 272 M | 272 M | 272 M | 272 M | 232 M | 232 M | 232 M | 232 M | 53.4 M | 53.4 M | 53.4 M | 53.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.64 B | 53.4 M | 417 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Boston Scientific Corporation
BSX
|
43.7 B | $ 62.59 | -0.37 % | $ 92.7 B | ||
|
AdaptHealth Corp.
AHCO
|
4.32 B | $ 12.07 | 0.33 % | $ 1.63 B | ||
|
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.59 | 1.2 % | $ 36.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | ||
|
Delcath Systems
DCTH
|
124 M | $ 9.7 | 0.73 % | $ 347 M | ||
|
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | ||
|
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | ||
|
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | ||
|
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.45 | 1.77 % | $ 129 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | ||
|
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 81.19 | 0.17 % | $ 47.5 B | ||
|
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | ||
|
FONAR Corporation
FONR
|
199 M | $ 18.6 | 0.05 % | $ 122 M | ||
|
Butterfly Network
BFLY
|
256 M | $ 4.13 | 0.49 % | $ 874 M | ||
|
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
5.81 B | $ 36.74 | -0.05 % | $ 5.47 K | ||
|
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | ||
|
AxoGen
AXGN
|
222 M | $ 32.64 | -5.23 % | $ 1.5 B | ||
|
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.9 | 2.15 % | $ 1.15 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.31 | -2.31 % | $ 717 M | ||
|
Inogen
INGN
|
299 M | $ 6.36 | 2.42 % | $ 169 M | ||
|
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | ||
|
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.0 | 1.66 % | $ 16.9 M | ||
|
IRadimed Corporation
IRMD
|
109 M | $ 95.66 | -0.59 % | $ 1.22 B | ||
|
Integer Holdings Corporation
ITGR
|
3.41 B | $ 85.63 | -1.4 % | $ 2.97 B | ||
|
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | ||
|
Align Technology
ALGN
|
6.21 B | $ 171.87 | 0.74 % | $ 12.9 B | ||
|
Eargo
EAR
|
132 M | - | - | $ 10.2 M | ||
|
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.94 | -0.75 % | $ 374 M | ||
|
LENSAR
LNSR
|
71.4 M | $ 5.89 | -2.81 % | $ 70.4 M | ||
|
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | ||
|
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.38 | 0.11 % | $ 266 M | ||
|
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | ||
|
Pulmonx Corporation
LUNG
|
129 M | $ 1.36 | 2.26 % | $ 55.3 M | ||
|
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | ||
|
Medtronic PLC
MDT
|
91.7 B | $ 86.28 | -0.4 % | $ 111 B | ||
|
MiMedx Group
MDXG
|
343 M | $ 3.88 | -1.02 % | $ 573 M | ||
|
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M | ||
|
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
38.6 M | $ 0.7 | 4.84 % | $ 29.3 M | ||
|
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | ||
|
Orthofix Medical
OFIX
|
851 M | $ 11.77 | 2.08 % | $ 466 M | ||
|
PAVmed
PAVM
|
38.8 M | $ 10.04 | 1.93 % | $ 6.73 M |